Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clarification to the systematic review and meta-analysis involving tigecycline.

Literature DB >> 21921119

Clarification to the systematic review and meta-analysis involving tigecycline.

Paul McGovern, Timothy Babinchak, Alvaro Quintana.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2011 PMID： 21921119 PMCID： PMC3187010 DOI： 10.1128/AAC.00512-11

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

Keyword Cloud
References

× No keyword cloud information.

12 in total

1. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.

Authors: Antonio T Freire; Vasyl Melnyk; Min Ja Kim; Oleksiy Datsenko; Oleksandr Dzyublik; Felix Glumcher; Yin-Ching Chuang; Robert T Maroko; Gary Dukart; C Angel Cooper; Joan M Korth-Bradley; Nathalie Dartois; Hassan Gandjini
Journal: Diagn Microbiol Infect Dis Date: 2010-10 Impact factor: 2.803

Review 2. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Authors: Yun Cai; Rui Wang; Beibei Liang; Nan Bai; Youning Liu
Journal: Antimicrob Agents Chemother Date: 2010-12-20 Impact factor: 5.191

3. A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections.

Authors: S Towfigh; J Pasternak; A Poirier; H Leister; T Babinchak
Journal: Clin Microbiol Infect Date: 2010-08 Impact factor: 8.067

4. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.

Authors: Sarvajna Sacchidanand; Robert L Penn; John M Embil; Maria E Campos; Daniel Curcio; Evelyn Ellis-Grosse; Evan Loh; Gilbert Rose
Journal: Int J Infect Dis Date: 2005-09 Impact factor: 3.623

5. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

Authors: Carlos Bergallo; Abel Jasovich; Osvaldo Teglia; Maria Eugenia Oliva; Arnold Lentnek; Luisa de Wouters; Juan Carlos Zlocowski; Gary Dukart; Angel Cooper; Rajiv Mallick
Journal: Diagn Microbiol Infect Dis Date: 2008-11-05 Impact factor: 2.803

6. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.

Authors: Zhangjing Chen; Jufang Wu; Yingyuan Zhang; Junming Wei; Xisheng Leng; Jianwei Bi; Rong Li; Lunan Yan; Zhiwei Quan; Xiaoping Chen; Yunsong Yu; Zhiyong Wu; Dawei Liu; Xiaochun Ma; Robert Maroko; Angel Cooper
Journal: BMC Infect Dis Date: 2010-07-21 Impact factor: 3.090

7. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.

Authors: I Florescu; M Beuran; R Dimov; A Razbadauskas; M Bochan; G Fichev; G Dukart; T Babinchak; C A Cooper; E J Ellis-Grosse; N Dartois; H Gandjini
Journal: J Antimicrob Chemother Date: 2008-09 Impact factor: 5.790